# Regencell Bioscience Holdings Limited (RGC)

> Source: Nexqual · https://nexqual.com/RGC · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Regencell Bioscience Holdings Limited (RGC), nexqual.com/RGC" · informational, not investment advice.

**Price:** USD 9.52 (+17.39% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 8.11 · day 7.72–11.12 · 52w 4.51–69 · market cap $4.72B · NCM

## Key facts
- Analysts: None.
- Total return with dividends: 1Y -47.0% vs S&P 500 +18.1%; 5Y +1840.8% vs S&P 500 +85.1%.
- Next earnings: 2026-10-28, EPS estimate USD —, revenue estimate null.

## Analysts
Consensus None.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -47.0% | +1840.8% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -47.1% | +80.7% |
| Volatility (annualized) | 139.1% | 187.7% |
| Max drawdown | -91.0% (Jan 2026→Jul 2026) | -92.1% (Jun 2022→Jun 2024) |

## Peers (Drug Manufacturers - Specialty & Generic)
KNSA (Kiniksa Pharmaceuticals Interna) USD 79.94 +1.80% · LNTH (Lantheus Holdings, Inc.) USD 99.99 -0.03% · HIMS (Hims & Hers Health, Inc.) USD 29.38 -1.11% · ALKS (Alkermes plc) USD 40.1 +0.93% · INDV (Indivior Pharmaceuticals, Inc.) USD 33.62 -5.08% · AMRX (Amneal Pharmaceuticals, Inc.) USD 19.25 -1.64%

## More
Full page: https://nexqual.com/RGC · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt